The week in health tech, explained in plain English.Get the free newsletter →
November 8, 2026

Takeaways from the most recent news in the technology and policies shaping healthcare.

Government

CMS Expands ACCESS Model to Four New Chronic Conditions

CMS is widening the reach of its ACCESS Model, an outcomes-based payment program that launched in July with 160 participating providers. Starting in spring 2027, the model will add four new chronic conditions: heart failure, COPD, substance use disorders and tobacco cessation, according to MedCity News.

The expansion changes the scale of the program. Once the new tracks go live, roughly three in four Medicare beneficiaries will be eligible for at least one, turning ACCESS from a targeted pilot into a broad test of paying providers based on patient outcomes rather than volume of services.

For providers, the additions cover some of the most common and costly conditions in the Medicare population. Heart failure and COPD drive frequent hospitalizations, while substance use and tobacco use are major upstream cost drivers. The move signals CMS's continued push toward value-based arrangements and gives participating organizations more room to build outcome-focused care around chronic disease management.

More in Government

Government

BIO Sues to Block Medicare Peer-Country Drug Pricing Pilot

BIO has sued to block a Medicare pilot that ties certain US drug prices to peer-country benchmarks, the latest challenge to Trump's most-favored-nation pricing push.

Why it matters: The outcome will shape how far the federal government can use Medicare pilots to push US drug prices toward what other countries pay.

Government

CMS Finalizes 2.4% Home Health Pay Bump for 2027

CMS finalized a 2.4% home health payment increase for 2027 while tightening Medicare provider enrollment rules to fight fraud.

Why it matters: The rule sets 2027 reimbursement for home health agencies and raises compliance stakes as CMS cracks down on fraud.

Government

CMS Makes Medicare Drug Price Negotiation Rules Permanent

CMS finalized a rule making its Medicare Drug Price Negotiation Program framework permanent, setting lasting policies for negotiated prices starting in 2029.

Why it matters: A permanent framework gives drugmakers, payers, and providers a stable rulebook to plan pricing and contracting around instead of chasing year-by-year changes.